Sg Americas Securities, LLC Blueprint Medicines Corp Transaction History

Sg Americas Securities, LLC

  • $30.5 Billion
  • Q1 2025

A detailed history of Sg Americas Securities, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Sg Americas Securities, LLC holds 7,276 shares of BPMC stock, worth $740,987. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,276
Previous 4,277 70.12%
Holding current value
$740,987
Previous $373,000 72.65%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 15, 2025
BUY
$86.69 - $115.63 $259,983 - $346,774
2,999 Added 70.12%
7,276 $644,000
Q4 2024

Jan 17, 2025
BUY
$82.48 - $101.39 $144,834 - $178,040
1,756 Added 69.65%
4,277 $373,000
Q3 2024

Oct 03, 2024
SELL
$84.1 - $120.5 $1.61 Million - $2.31 Million
-19,163 Reduced 88.37%
2,521 $233,000
Q2 2024

Jul 12, 2024
BUY
$85.18 - $108.78 $836,382 - $1.07 Million
9,819 Added 82.76%
21,684 $2.34 Million
Q1 2024

May 06, 2024
BUY
$73.17 - $99.79 $469,166 - $639,853
6,412 Added 117.59%
11,865 $1.13 Million
Q4 2023

Jan 12, 2024
SELL
$43.96 - $92.84 $1.23 Million - $2.6 Million
-28,025 Reduced 83.71%
5,453 $503,000
Q3 2023

Oct 13, 2023
BUY
$46.9 - $66.0 $1.47 Million - $2.07 Million
31,299 Added 1436.39%
33,478 $1.68 Million
Q2 2023

Jul 10, 2023
BUY
$42.2 - $66.37 $91,953 - $144,620
2,179 New
2,179 $138,000
Q3 2022

Oct 31, 2022
SELL
$49.93 - $77.7 $391,750 - $609,634
-7,846 Reduced 40.48%
11,537 $760,000
Q2 2022

Jul 29, 2022
BUY
$45.23 - $70.15 $53,778 - $83,408
1,189 Added 6.54%
19,383 $979,000
Q1 2022

Apr 29, 2022
SELL
$54.1 - $110.08 $975,585 - $1.99 Million
-18,033 Reduced 49.78%
18,194 $1.16 Million
Q4 2021

Feb 07, 2022
BUY
$94.25 - $115.99 $1.14 Million - $1.4 Million
12,052 Added 49.85%
36,227 $3.88 Million
Q3 2021

Nov 01, 2021
BUY
$80.98 - $109.47 $326,268 - $441,054
4,029 Added 20.0%
24,175 $2.49 Million
Q2 2021

Aug 12, 2021
BUY
$82.78 - $101.0 $763,148 - $931,119
9,219 Added 84.37%
20,146 $1.77 Million
Q1 2021

May 13, 2021
BUY
$90.71 - $108.28 $775,389 - $925,577
8,548 Added 359.31%
10,927 $1.06 Million
Q4 2020

Feb 04, 2021
SELL
$92.08 - $124.48 $2.01 Million - $2.71 Million
-21,805 Reduced 90.16%
2,379 $267,000
Q3 2020

Nov 09, 2020
SELL
$66.45 - $92.7 $631,275 - $880,650
-9,500 Reduced 28.2%
24,184 $2.24 Million
Q2 2020

Jul 20, 2020
BUY
$57.09 - $79.27 $1.06 Million - $1.47 Million
18,548 Added 122.54%
33,684 $2.63 Million
Q1 2020

Apr 30, 2020
SELL
$48.11 - $82.22 $35,168 - $60,102
-731 Reduced 4.61%
15,136 $885,000
Q4 2019

Jan 28, 2020
BUY
$66.73 - $82.59 $711,208 - $880,244
10,658 Added 204.61%
15,867 $1.27 Million
Q3 2019

Nov 04, 2019
BUY
$72.9 - $101.41 $176,053 - $244,905
2,415 Added 86.44%
5,209 $383,000
Q2 2019

Jul 29, 2019
SELL
$73.54 - $97.8 $410,279 - $545,626
-5,579 Reduced 66.63%
2,794 $264,000
Q1 2019

Apr 29, 2019
SELL
$48.7 - $86.6 $77,384 - $137,607
-1,589 Reduced 15.95%
8,373 $670,000
Q4 2018

Feb 01, 2019
BUY
$45.57 - $74.26 $376,408 - $613,387
8,260 Added 485.31%
9,962 $537,000
Q3 2018

Nov 06, 2018
SELL
$58.91 - $78.32 $101,619 - $135,102
-1,725 Reduced 50.34%
1,702 $133,000
Q2 2018

Aug 07, 2018
BUY
$60.96 - $101.18 $17,373 - $28,836
285 Added 9.07%
3,427 $218,000
Q1 2018

May 03, 2018
BUY
$73.28 - $102.95 $230,245 - $323,468
3,142 New
3,142 $288,000
Q4 2017

Jan 24, 2018
SELL
$62.91 - $88.32 $545,618 - $765,999
-8,673 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$42.37 - $69.67 $367,475 - $604,247
8,673
8,673 $604,000

Others Institutions Holding BPMC

# of Institutions
394
Shares Held
61.2M
Call Options Held
1.6M
Put Options Held
1.41M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $6.08B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email